Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals

by Scott Larrivee | May 4, 2023 | News

Virtual event will take place on Friday, May 12, 2023 at 10 a.m. EST Register NEW YORK – May 4, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will host a virtual Key Opinion Leader (KOL) event on Friday,...

Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

by Scott Larrivee | May 1, 2023 | News

Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...

Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event

by Scott Larrivee | Apr 20, 2023 | News

NEW YORK – April 20, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced its co-founder and Chief Operating Officer (COO), Dr. Howard Lewin, will take part in a virtual event hosted by Truist Securities on Friday,...

Nusano to Present at Jefferies Inaugural Radiopharma Innovation Summit

by Scott Larrivee | Mar 27, 2023 | News

NEW YORK and VALENCIA, Calif. – March 27, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will present and participate in a panel discussion at Jefferies Inaugural Radiopharma Innovation Summit in New York...